Cannabinoid News and Research

Latest Cannabinoid News and Research

Keynote speakers announced for CBD Expo MIDWEST

CBD Expo Tour 2019, produced by MACE Media Group, one of the nation’s largest diversified media and information companies in the cannabis space and publisher of Terpenes and Testing Magazine, announced Celeste Miranda and Adam Dr. Adam Abodeely, MD, MBA, FACS, FASCRS will be the keynote speakers for CBD Expo MIDWEST in Indianapolis, Indiana to take place on March 15-16, 2019.

From CBD Expo Midwest 13 Feb 2019

Cannabinoid receptor type 1 appears to be potential target to treat Down syndrome

A study by the Neuropharmacology Laboratory-NeuroPhar of the Department of Experimental and Health Sciences at UPF reveals the involvement of the endocannabinoid system in cognitive disorders in mouse models of Down syndrome.

7 Feb 2019

Cannabinoid compounds may reduce viability of colon cancer cells

Medical marijuana has gained attention in recent years for its potential to relieve pain and short-term anxiety and depression. Now, Penn State College of Medicine researchers say some cannabinoid compounds may actually inhibit the growth of colon cancer cells in the lab.

6 Feb 2019

Are Electronic Cigarettes Facilitating Illicit Drug Use?

In this interview, Dr. Michelle Peace provides an introduction to her research into the use of e-cigarettes for the inhalation of illicit drugs.

From Pittcon 5 Feb 2019

New sessions at Pittcon 2019

Pittcon 2019 will be held March 17-21, 2019 in Philadelphia PA at the Pennsylvania Convention Center. A number of new events and sessions will be held.

From Pittcon 23 Jan 2019

Low-level cannabis use can change the adolescent brain

Teenagers who report using recreational marijuana just once or twice display increased volume of numerous brain regions, according to a study of 14-year-olds from Ireland, England, France, and Germany.

From Society for Neuroscience 16 Jan 2019

Therapeutic implications of caffeine in neuropsychiatric disorders

An important new article reviews recently discovered properties of adenosine A2A receptor-dopamine D2 receptor and adenosine A1 receptor-dopamine D1 receptor heteromers--both of which are main targets for caffeine--and discusses the therapeutic implications of these findings.

7 Jan 2019

Experts address sleep disorders following traumatic brain injury

Disorders of sleep are some of the most common problems experienced by patients after traumatic brain injury. It is important to recognize and treat these problems early to allow for optimal cognitive recovery, but because they are so common, the importance of treating them is often underestimated.

10 Dec 2018

Cannabis-based compound shows promise to reduce seizures in children with epilepsy

Interest has been growing in the use of cannabinoids--the active chemicals in cannabis or marijuana-- for the treatment of epilepsy in children. A recent Epilepsia analysis of relevant published studies indicates that this strategy looks promising.

5 Dec 2018

NanoSphere develops new intraoral product that has potential to revolutionize cannabis therapies

NanoSphere Health Sciences Inc. is pleased to announce the Company has developed a new intraoral delivered cannabis product for the Canadian market, which produces similar effects to smoking cannabis, but is safer and more effective than edibles.

26 Nov 2018

Cannabinoids hold promise in treating children with epilepsy

In recent years, cannabinoids--the active chemicals in medical marijuana-- have been increasingly touted as a potential treatment for a range of neurological and psychiatric disorders. In a Developmental Medicine & Child Neurology review, investigators compare their efficacy with antiepileptic drugs for children with epilepsy.

7 Nov 2018

Effective dose of cannabidiol for safe pain relief without the typical 'high'

In the wake of cannabis legalization, a team of scientists at the Research Institute of the McGill University Health Center and McGill University have delivered encouraging news for chronic pain sufferers by pinpointing the effective dose of marijuana plant extract cannabidiol for safe pain relief without the typical "high" or euphoria produced by the THC.

25 Oct 2018